| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 61.638 | 91.355 | 98.842 | 106.246 | 96.053 | 70.939 | 93.400 | 79.135 | 81.549 | 78.912 |
| Total Income - EUR | 61.682 | 91.441 | 99.250 | 106.442 | 96.175 | 70.954 | 93.420 | 81.152 | 82.130 | 78.962 |
| Total Expenses - EUR | 44.140 | 64.296 | 69.287 | 82.688 | 76.043 | 60.074 | 75.636 | 68.233 | 71.059 | 68.676 |
| Gross Profit/Loss - EUR | 17.542 | 27.145 | 29.963 | 23.754 | 20.132 | 10.880 | 17.784 | 12.920 | 11.071 | 10.287 |
| Net Profit/Loss - EUR | 15.692 | 25.159 | 26.998 | 20.576 | 17.248 | 8.919 | 15.037 | 10.590 | 9.315 | 8.541 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pedibed Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 13.621 | 10.028 | 6.556 | 3.216 | 0 | 3.276 | 4.293 | 4.119 |
| Current Assets | 50.303 | 58.244 | 84.614 | 77.916 | 89.590 | 68.664 | 94.136 | 88.705 | 84.461 | 66.740 |
| Inventories | 11.115 | 28.208 | 38.622 | 51.809 | 61.420 | 52.179 | 74.674 | 73.715 | 71.922 | 45.111 |
| Receivables | 5.369 | 5.649 | 9.683 | 10.118 | 11.828 | 4.494 | 7.927 | 7.985 | 6.187 | 9.752 |
| Cash | 33.819 | 24.387 | 36.309 | 15.989 | 16.342 | 11.991 | 11.535 | 7.005 | 6.352 | 11.878 |
| Shareholders Funds | 35.133 | 55.480 | 66.215 | 72.683 | 75.880 | 66.439 | 71.282 | 67.010 | 65.564 | 54.204 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.171 | 2.764 | 32.019 | 15.261 | 20.266 | 5.441 | 22.854 | 24.972 | 23.190 | 16.655 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4642 - 4642" | |||||||||
| CAEN Financial Year |
4642
|
|||||||||
Comments - Pedibed Bio Srl